Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies
- PMID: 24180357
- PMCID: PMC3817892
- DOI: 10.1089/dia.2013.0131
Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies
Abstract
Background: Increasing evidence suggests that diabetes mellitus (DM) may be associated with an increased risk of bladder cancer. We performed an updated meta-analysis to examine the association between DM and risk of bladder cancer.
Materials and methods: We systematically searched the EMBASE and Medline (PubMed) databases (from inception through February 1, 2013) and reviewed the reference lists of relevant publications to search for additional studies. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated with random-effects models.
Results: In total, 10 case-control and 14 cohort studies met the inclusion criteria. Analysis of all studies showed that DM was associated with an increased risk of bladder cancer (RR 1.30, 95% CI 1.18-1.43). There was heterogeneity among studies (Pheterogeneity <0.001, I(2)=81.5%). Cohort studies showed a lower risk (RR 1.23, 95% CI 1.09-1.37) than case-control studies (odds ratio 1.46, 95% CI 1.20-1.78). The positive association was significant only in women (RR 1.23, 95% CI 1.02-1.49), but not in men (RR 1.07, 95% CI 0.97-1.18). The combined RRs remained unchanged before and after the studies on type 1 diabetes were excluded from analysis. The association between DM and bladder cancer risk did not differ significantly by methods of DM ascertainment. The combined RRs were 1.17 (95% CI 1.03-1.34), 1.34 (95% CI 1.19-1.51), and 1.57 (95% CI 0.96-2.55), respectively, when restricting the analysis to the studies accounting for body mass index, cigarette smoking, or glucose-lowering drug use.
Conclusions: This meta-analysis indicates a positive association between DM and risk of bladder cancer. Further studies are warranted to determine whether DM prevention and control can reduce risk of bladder cancer.
Figures
![FIG. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3817892/bin/fig-1.gif)
![FIG. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3817892/bin/fig-2.gif)
![FIG. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3817892/bin/fig-3.gif)
Similar articles
-
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.BMC Cancer. 2013 Jun 26;13:310. doi: 10.1186/1471-2407-13-310. BMC Cancer. 2013. PMID: 23803148 Free PMC article. Review.
-
Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922. doi: 10.1038/ajg.2011.301. Epub 2011 Sep 13. Am J Gastroenterol. 2011. PMID: 21912438 Free PMC article. Review.
-
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.PLoS One. 2013;8(2):e56662. doi: 10.1371/journal.pone.0056662. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437204 Free PMC article.
-
Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.Medicine (Baltimore). 2017 Nov;96(46):e8588. doi: 10.1097/MD.0000000000008588. Medicine (Baltimore). 2017. PMID: 29145273 Free PMC article.
-
Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis.Asian Pac J Cancer Prev. 2013;14(4):2583-9. doi: 10.7314/apjcp.2013.14.4.2583. Asian Pac J Cancer Prev. 2013. PMID: 23725179
Cited by
-
Interethnic Differences in Bladder Cancer Incidence and the Association between Type 2 Diabetes and Bladder Cancer in the Multiethnic Cohort Study.Cancer Res Commun. 2023 May 2;3(5):755-762. doi: 10.1158/2767-9764.CRC-22-0288. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377897 Free PMC article.
-
The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study.J Gastrointest Oncol. 2023 Apr 29;14(2):798-805. doi: 10.21037/jgo-23-134. J Gastrointest Oncol. 2023. PMID: 37201057 Free PMC article.
-
Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.Cancer Med. 2023 Apr;12(8):10031-10044. doi: 10.1002/cam4.5743. Epub 2023 Mar 23. Cancer Med. 2023. PMID: 36951550 Free PMC article.
-
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.Cancers (Basel). 2022 Nov 25;14(23):5811. doi: 10.3390/cancers14235811. Cancers (Basel). 2022. PMID: 36497303 Free PMC article. Review.
-
Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study.Front Oncol. 2022 Oct 3;12:996440. doi: 10.3389/fonc.2022.996440. eCollection 2022. Front Oncol. 2022. PMID: 36263231 Free PMC article.
References
-
- The IDF Diabetes Atlas. 5th. www.idf.org/diabetesatlas/5e/diabetes. [Feb 5;2013 ]. www.idf.org/diabetesatlas/5e/diabetes
-
- Attner B. Landin-Olsson M. Lithman T. Noreen D. Olsson H. Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes Control. 2012;23:769–777. - PubMed
-
- Jee SH. Ohrr H. Sull JW. Yun JE. Ji M. Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194–202. - PubMed
-
- U.S. Cancer Statistics Working Group. Atlanta: Centers for Disease Control and Prevention, Department of Health and Human Services, and National Cancer Institute; 2010. United States Cancer Statistics: 1999–2006 Incidence and Mortality Web-Based Report.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous